ATE132375T1 - Neuramidase und glulaktoseoxidase als vaccinadjuvans - Google Patents

Neuramidase und glulaktoseoxidase als vaccinadjuvans

Info

Publication number
ATE132375T1
ATE132375T1 AT91914344T AT91914344T ATE132375T1 AT E132375 T1 ATE132375 T1 AT E132375T1 AT 91914344 T AT91914344 T AT 91914344T AT 91914344 T AT91914344 T AT 91914344T AT E132375 T1 ATE132375 T1 AT E132375T1
Authority
AT
Austria
Prior art keywords
vaccinadjuvans
glulactose
neuramidase
oxidase
neuraminidase
Prior art date
Application number
AT91914344T
Other languages
English (en)
Inventor
John Richard Rhodes
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Application granted granted Critical
Publication of ATE132375T1 publication Critical patent/ATE132375T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55516—Proteins; Peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT91914344T 1990-08-17 1991-08-16 Neuramidase und glulaktoseoxidase als vaccinadjuvans ATE132375T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909018061A GB9018061D0 (en) 1990-08-17 1990-08-17 Compositions for vaccines

Publications (1)

Publication Number Publication Date
ATE132375T1 true ATE132375T1 (de) 1996-01-15

Family

ID=10680805

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91914344T ATE132375T1 (de) 1990-08-17 1991-08-16 Neuramidase und glulaktoseoxidase als vaccinadjuvans

Country Status (10)

Country Link
US (1) US6383498B1 (de)
EP (1) EP0544712B1 (de)
JP (1) JP3051760B2 (de)
AT (1) ATE132375T1 (de)
DE (1) DE69116155T2 (de)
DK (1) DK0544712T3 (de)
ES (1) ES2082221T3 (de)
GB (1) GB9018061D0 (de)
GR (1) GR3019525T3 (de)
WO (1) WO1992003164A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5872151A (en) * 1992-10-01 1999-02-16 Glaxo Wellcome Inc. Immunopotentiatory agents and physiologically acceptable salts thereof
DE69306545T2 (de) * 1992-10-01 1997-04-03 Wellcome Found Tucaresol als Mittel zur Immunopotentierung
US5958980A (en) * 1993-08-26 1999-09-28 Glaxo Wellcome, Inc. Immunopotentiatory agent and physiologically acceptable salts thereof
AU2003901008A0 (en) 2003-03-04 2003-03-20 Anadis Ltd Composition for the treatment and prevention of bacterial infections
AU2013323472B2 (en) 2012-09-28 2018-07-05 Ellis KLINE Glycosidase regimen for treatment of infectious disease
US10253294B2 (en) * 2013-12-18 2019-04-09 Julius-Maximilians-Universität Würzburg Galactose oxidase treatment of dendritic cells to improve their immunogenicity

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL301025A (de) * 1962-11-28 1900-01-01
DE2620649C3 (de) * 1976-05-11 1980-11-06 Behringwerke Ag, 3550 Marburg Immunologisches Adjuvans

Also Published As

Publication number Publication date
EP0544712A1 (de) 1993-06-09
DK0544712T3 (da) 1996-03-04
JPH06500086A (ja) 1994-01-06
GR3019525T3 (en) 1996-07-31
EP0544712B1 (de) 1996-01-03
WO1992003164A1 (en) 1992-03-05
DE69116155T2 (de) 1996-09-05
US6383498B1 (en) 2002-05-07
JP3051760B2 (ja) 2000-06-12
DE69116155D1 (de) 1996-02-15
GB9018061D0 (en) 1990-10-03
ES2082221T3 (es) 1996-03-16

Similar Documents

Publication Publication Date Title
DK0689454T4 (da) Vaccinepræparater indeholdende 3-O-deacyleret monophosphoryl-lipid A
DK0865297T3 (da) Vaccinesammensætninger til intranasal administration omfattende chitosan og anvendelsen deraf
FI943171L (fi) Ureaasipohjainen rokote Helicobacter-infektiota vastaan
NO911731L (no) Ultrasonisk maaleapparat og -fremgangsmaate.
FI923378L (fi) Stabiliserade mikroorganismkulturer.
DE69533673D1 (de) Behandlung und prävention von helicobacter-infektionen
EA199900069A1 (ru) Вакцинная композиция против малярии
ATE132375T1 (de) Neuramidase und glulaktoseoxidase als vaccinadjuvans
DE69029656D1 (de) Azellulärer impfstoff
DE69021761D1 (de) Impfstoff gegen Tinea.
NO875038D0 (no) Konjugert vaksine.
ES2152315T3 (es) Xamoneline tartrato.
FI944563A0 (fi) Mikro-organismeja, valmistusmenetelmä ja käyttö
DE69016693D1 (de) Züchtung von transformierten Mikroorganismen.
DE68918189D1 (de) Neisseria-Vakzine.
UA42741C2 (uk) Пептид маститної вакцини (варіанти), пептид складного антигенного представлення (варіанти), фармацевтична композиція (варіанти)
NO910039L (no) Ikke-beskadigende overhalings- og fullfoeringsfluid.
DE68927340D1 (de) Biologischer impfstoff, wirksam gegen aphanomyces
IT216195Z2 (it) Ventilatore indossabile ed usabile come diffusore di profumi.
ES2141923T3 (es) Uso hipocolesterolemico, antiaterosclerotico e hipotrigliceridemico de derivados aminoacetilmercapto.
IT8848064A0 (it) Dispositivo meccanico per l'abbatti mento pilotato delle polveri, per macchine ad aspirazione di prodotti agricoli e simili
ATE144103T1 (de) Biologischer impfstoff, wirksam gegen aphanomyces
NO892920D0 (no) Baerbart aksel- og rammejusteringsredskap.
IT8620480V0 (it) Giunto per intelaiature particolarmente di espositori e simili.
IL94510A0 (en) Influenza vaccine

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee